BDNF exon IV promoter methylation and antidepressant action: a complex interplay

BDNF exon IV promoter methylation is a potential biomarker for treatment response to antidepressants in MDD. We have previously shown CpG-87 methylation as a successful biomarker for the prediction of non-resp...

Source: Clinical Epigenetics - December 26, 2022 Category: Research Authors: Hansi Pathak, Anton Borchert, Sara Garaali, Alexandra Burkert and Helge Frieling Tags: Research Source Type: research